Unamuno X, Gmez-Ambrosi J, Rodrguez A, Becerril S, Frhbeck G, Cataln V
Third-party tested for purity and heavy metals free
Medical therapies for IBD include oral or rectal 5-ASA drugs, immunomodulators, biologicals, and other newer agents with different targets and mechanisms of action For patients with mild to moderate UC, 5-ASA drugs are effective for achieving remission and maintenance Rarely, patients have serious adverse events with 5-ASA drugs (eg, interstitial nephritis, pericarditis, pneumonitis, hepatitis, or pancreatitis) Antibiotics Controlled trials of various antibiotics have not demonstrated efficacy in treating UC
[DOI] [PMC free article] [PubMed] [Google Scholar] 60.Piechowiak T., Grzelak-Baszczyk K., Sjka M., Balawejder M
Plasma Biomarkers of Inflammation, the Kynurenine Pathway, and Risks of All-Cause, Cancer, and Cardiovascular Disease Mortality: The Hordaland Health Study